CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial Diuretic Therapy for Patients With Heart Failure JACC State-of-the-Art Review Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial The year in cardiovascular medicine 2020: heart failure and cardiomyopathies Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients - A Systematic Review and Meta-Analysis Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Ambulatory Inotrope Infusions in Advanced Heart Failure - A Systematic Review and Meta-Analysis Mechanical circulatory support devices in advanced heart failure: 2020 and beyond

Guideline2018 Oct 24;46(10):760-789.

JOURNAL:中华心血管病杂志 Article Link

中国心力衰竭诊断和治疗指南2018

中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会中华心血管病杂志编辑委员会 Keywords: heart failure; guideline; China

LINK


自"中国心力衰竭诊断和治疗指南2014"发布以来,心力衰竭(心衰)的诊疗、预防及综合管理等相关领域有不少新进展,为此,中华医学会心血管病学分会心力衰竭学组、中国医师协会心力衰竭专业委员会、中华心血管病杂志编辑委员会组织专家组,根据国内外最新临床研究成果,参考2017年美国心脏病学会(ACC)/美国心脏协会(AHA)以及2016年欧洲心脏病学会(ESC)等发布的相关指南,结合我国国情及临床实践,对"中国心力衰竭诊断和治疗指南2014"进行更新。